Tertiary lymphoid structure-related genes drive tumor microenvironment heterogeneity and prognostic disparities in left- vs. right-sided colon cancer
Authors:
- Hongyi ZhouHZHongyi Zhou
- Xiaohong QianXQXiaohong Qian
- Qiujun DaiQDQiujun Dai
- Qiqi ZhuQZQiqi Zhu
- Peiyuan LiPLPeiyuan Li
- Wei CuiWCWei Cui
- Yibin ZhaoYZYibin Zhao
Open Access
- 1 April 2026
- journal article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (4) , 270
Abstract
Background: Colorectal cancer (CRC) exhibits significant heterogeneity between left-sided (LCC) and right-sided (RCC) subtypes, influenced by tertiary lymphoid structures-related genes (TLSRGs). This study aimed to explore TLSRGs’ roles in LCC/RCC differences, including expression, mutations, prognosis, and molecular pathways, while developing a prognostic risk model. Methods: Data were integrated from The Cancer Genome Atlas Colon Adenocarcinoma (TCGA-COAD) (324 samples: 135 LCC, 189 RCC) and Gene Expression Omnibus (GEO) datasets. TLSRGs were analyzed for differential expression, mutations, and prognostic associations using Wilcoxon tests, Cox regression, and gene set variation analysis (GSVA). Consensus clustering identified molecular subtypes. Single-cell analysis involved Seurat/Harmony for clustering and annotation, single-sample gene set enrichment analysis (ssGSEA) for scoring, and CellChat for cell communication. A machine learning-based risk model was constructed by screening ten algorithms (including SuperPC, RSF, CoxBoost, etc.) using the Mime package. The SuperPC algorithm demonstrated the best performance and was built on TLSRGs and related pathways, validated via Concordance index (C-index), Kaplan-Meier (KM) curves, and receiver operating characteristic (ROC) analysis. Results: Integrated analysis revealed significant heterogeneity between LCC and RCC, characterized by distinct somatic mutation profiles, differential expression of 27 TLSRGs, and subtype stratification via TLSRG-based consensus clustering (C1 enriched in RCC, PFBLN7 [hazard ratio (HR) =7.09 for disease-specific survival (DSS)] and MS4A1 [HR =7.79 for disease-free interval (DFI)] predicted poor survival in LCC, while ICOS was protective in RCC [HR =0.42 for overall survival (OS)]. Drug sensitivity screening identified 22 agents with differential half-maximal inhibitory concentration (IC50) correlated to TLSRG expression, and immune infiltration analysis revealed reduced CD8+ T cells/follicular helper T cells in RCC. An 8-gene prognostic signature (HSPB1, NCOR2, STIL, etc.) derived via SuperPC effectively stratified high-risk patients in TCGA (HR =2.06, P=0.001) and GSE103479 (HR =1.86, P=0.02), with consistent performance across LCC/RCC subgroups. Conclusions: TLSRGs underpin LCC/RCC heterogeneity in mutations, expression, immunity, and cell interactions. The developed risk model offers robust prognostic value, highlighting potential therapeutic targets for sidedness-specific CRC management.Keywords
This publication has 64 references indexed in Scilit:
- Blockade of the chemokine receptor, CCR5, reduces the growth of orthotopically injected colon cancer cells via limiting cancerassociated fibroblast accumulationOncotarget, 2016
- Knockdown of asparagine synthetase (ASNS) suppresses cell proliferation and inhibits tumor growth in gastric cancer cellsScandinavian Journal of Gastroenterology, 2016
- The Na+/HCO3−Co-Transporter SLC4A4 Plays a Role in Growth and Migration of Colon and Breast Cancer CellsJournal of Cellular Physiology, 2015
- MMP9 Processing of HSPB1 Regulates Tumor ProgressionPLOS ONE, 2014
- Metabolic Regulation of T LymphocytesAnnual Review of Immunology, 2013
- TGF-β-induced apoptosis of B-cell lymphoma Ramos cells through reduction of MS4A1/CD20Oncogene, 2012
- Cell-cycle-regulated expression of STIL controls centriole number in human cellsJournal of Cell Science, 2012
- Soluble HSPB1 regulates VEGF-mediated angiogenesis through their direct interactionAngiogenesis, 2012
- The Cystine/Glutamate Antiporter Regulates Dendritic Cell Differentiation and Antigen PresentationThe Journal of Immunology, 2010
- Structure, function, and post-translational regulation of the catalytic and modifier subunits of glutamate cysteine ligaseMolecular Aspects of Medicine, 2009